The Federal Government has granted the regulatory approval for the R21/Matrix developed by scientists at Oxford University. This was announced by the Director-General of the National Agency for Food and Drug Administration And Control (NAFDAC), Mojisola Adeyeye during a press briefing on Monday. Adeyeye said that the vaccine is to address the prevention of malaria in children from five months …